No name

Did you know that schizophrenia affects more than 1 percent of the world's population? See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

Schizohrenia research & FAQs


Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

Christopher R. Bowie, Ph.D., C.Psych., Director, Cognitive and Psychotic Disorders Laboratory and Associate Professor, Departments of Psychology & Psychiatry, Queen's University, Kingston, ON, Canada, Expert on Schizophrenia
Dr. Christopher Bowie
February 19, 2013

Dr. Christopher Bowie used his 2007 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation to conduct a study that shows how different types of psychological therapies for schizophrenia can be...

Kathryn A. Cunningham, Ph.D., Expert on depression from University of Texas Medical Branch (UTMB), Galveston
Dr. Kathryn A. Cunningham
February 15, 2013

Brain & Behavior Research Foundation NARSAD Grantee Kathryn A. Cunningham, Ph.D., with her team at University of Texas Medical Branch (UTMB), Galveston and collaborators at the University of Houston (UH), has found a...

Sarah Lisanby, M.D., Professor and Chair Psychiatry & Behavioral Sciences, Duke University School of Medicine, Expert on Depression
Sarah Lisanby, M.D.
February 14, 2013

This week the New York Times reports the latest research progress on transcranial direct current stimulation (tDCS) as a treatment for resistant major depression. More than a decade of research into the mild...

Meet the Scientist Webinar featuring Depression Expert, Myrna Weissman, Ph.D. of Columbia University and Brain & Behavior Research Foundation CEO, Jeffrey Borenstein
"Depression in Families" Webinar
February 14, 2013

On Tuesday, February 12, 2013, The Brain & Behavior Research Foundation presented a Meet the Scientist Webinar featuring Dr. Myrna Weissman of Columbia University. She presented an interactive presentation on "...

NARSAD Grantee Tsuyoshi Miyakawa, Ph.D., , expert on schizophrenia, at the Institute for Comprehensive Medical Science, Fujita Health University and the National Institute for Physiological Sciences, Japan
Tsuyoshi Miyakawa, Ph.D.
February 12, 2013

Researchers have discovered a protein deficiency that results in mild chronic brain inflammation and is thought to lead to schizophrenia-related symptoms, such as working memory deficits, self-neglect, decreased social...

Pages

Subscribe to